Photo: Shutterstock

FDA Approves First Ever Covid-19 Breath Test

The US Food and Drug Administration (FDA) has granted EUA to the first-ever Covid-19 breath test. The InspectIR Covid-19 Breathalyzer can produce results in less than three minutes. The device can separate and identify chemical mixtures, and detect five compounds associated with Sars-CoV2 infection in the exhaled breath of a person. The diagnostic test has more than 90% accuracy in identifying both positive and negative samples.

Sat, 16 Apr 2022 - 08:00 PM / by Varun Das

Tags: Covid-19, Covid-19 Test, Coronavirus Pandemic, Emergency Use Authorization, emergency use

Courtesy: CNN


Photo: Business Standard

WHO Requests Explanations On Covaxin; To Reconvene On November 3 For Final Review

WHO announced on October 26, that Technical-Advisory-Group (TAG) for Emergency-Use-Listing (EUL) has made the decision that added clarifications from Bharat-Biotech are required before a final EUL risk-benefit assessment for global use of Covaxin can be conducted. WHO stated that TAG “expects to receive these clarifications by the end of this week, and aims to reconvene on November 3”. Covaxin's acceptance by foreign countries is contingent… read-more

Wed, 27 Oct 2021 - 12:36 PM / by Vidhi Jhunjhunwala

Tags: Covaxin, Bharat biotech, WHO, Emergency Use Authorization

Courtesy: The Indian Express

Zydus Cadila Vaccine

Photo: The Print

Ahmedabad-Based Zydus Cadila's Covid Vaccine Awaits Govt Approval

After conducting the largest clinical trials in more than 50 centers, Zydus Cadila's three-dose Covid vaccine "ZyCoV-D" may soon get the government's approval for emergency use in India. The Gujarat-based pharmaceutical company has been listed for emergency use authorization (EAU) with the Indian Drug regulator and is likely to produce around 10-12 crore doses in a year. Reportedly, the ZyCoV-D vaccination will be administered to the adults… read-more

Mon, 09 Aug 2021 - 06:35 PM / by Prateek Chakradhar

Tags: Zydus Cadila, Covid-19, Covid Vaccination, Emergency Use Authorization

Courtesy: ANI

Zydus HQ

Photo: The Financial Express

Zydus COVID-19 Vaccine For Children To Launch Shortly In India

The government on June 27 declared that the vaccination process for children aged between 12 to 18 may start by July-end or August as the trials for Zydus Cadila is almost complete. The Zydus Cadila vaccine Zy-CoV-D will soon apply for authorisation for emergency use to the Drugs Controller General of India. The vaccine is asserted to be safe for use in both children and adults.

Mon, 28 Jun 2021 - 06:55 PM / by Sohini Mandal

Tags: Zydus Cadila, Coronavirus Vaccines, DRUG CONTROLLER GENERAL OF INDIA, Emergency Use Authorization

Courtesy: The Times of India

Pfizer Vaccine

Photo: The Economic Times

Vaccine: Pfizer Withdraws Emergency Use Authorization Plea In India

American pharmaceutical MNC Pfizer has withdrawn the Emergency Use Authorization application for its COVID-19 vaccine in India. Pfizer on February 5 said the decision had been taken after it met with the Drug Regulatory Authority of India. Withdrawing its request, the vaccine developer said the regulator has sought for extra information. However, Pfizer, which was first to seek emergency approval for the vaccine in India, has confirmed to re-… read-more

Fri, 05 Feb 2021 - 12:27 PM / by Nikita Thakur

Tags: Pfizer-BioNTech Vaccine, Emergency Use Authorization, Covid Vaccine

Courtesy: NDTV